Last updated: July 29, 2025
Introduction
Patent CL2012001927 pertains to a pharmaceutical invention filed and granted in Chile. Its precise scope, claims, and position within the existing patent landscape influence its enforceability, potential licensing opportunities, and strategic value. This analysis provides an in-depth review of the patent's scope, examining claims, and situating it within the broader patent landscape for pharmaceuticals, particularly in the context of Chilean and international patent systems.
1. Patent Overview
The patent CL2012001927 was filed in Chile in 2012, with a priority date generally corresponding to its filing date or an earlier priority document. Its publication indicates legal rights granted, typically covering specific pharmaceutical formulations, methods of use, or processes related to a particular medicinal compound or composition.
The inventors and assignee details are crucial for understanding the patent's ownership and licensing potential; however, these are not provided herein and would require access to Chilean patent databases or patent office documentation for confirmation.
2. Scope of the Patent and Key Claims
2.1. Claims Analysis Approach
Chilean patents, like many jurisdictions, define their scope through a series of claims—independent and dependent—that establish the legal boundaries of the invention. A comprehensive review involves analyzing the:
- Independent Claims: The broadest claims, establishing the core inventive concept.
- Dependent Claims: Narrower claims, adding specific limitations or embodiments.
The following points highlight the typical structure and focus of such claims in the context of pharmaceutical patents.
2.2. Likely Content of the Claims
While the actual claims text of CL2012001927 is not provided here, based on similar pharmaceutical patents, probable claim types include:
- Composition Claims: Covering specific pharmaceutical formulations, such as combinations of active pharmaceutical ingredients (APIs), excipients, stabilizers, or delivery systems.
- Method Claims: Descriptions of manufacturing processes, methods of administration, or therapeutic use of the composition.
- Use Claims: Patents often claim a novel therapeutic application, such as treating a particular disease or condition with the specified formulation.
- Device or Delivery System Claims: If applicable, claims may focus on specific delivery devices aiding in drug administration.
2.3. Scope and Breadth
The scope depends heavily on how broad the independent claims are drafted:
- Broad claims may cover a class of compounds or formulations, providing extensive protection but increasing the risk of patent invalidation if prior art exists.
- Narrow claims focus on specific compounds, doses, or manufacturing steps, offering narrower but more defensible rights.
Without the exact claims, it is prudent to assume the patent focuses on a particular therapeutic formulation or method to balance scope and validity.
2.4. Claim Quality and Patent Term
Typically, pharmaceutical patents aim for comprehensive claims to maximize market exclusivity within the constraints of prior art. Chilean patent law aligns with international standards via the TRIPS agreement, granting 20-year protection from the filing date, subject to maintenance fees.
3. Patent Landscape in Chile and International Context
3.1. Chile’s Pharmaceutical Patent Environment
Chile adheres to TRIPS commitments, with a patent system that recognizes pharmaceutical innovations as patentable subject matter, provided they fulfill novelty, inventive step, and industrial applicability requirements.
The country's patent landscape for pharmaceuticals is characterized by:
- Active pharmaceutical ingredients (APIs) patenting.
- Formulation and process patents.
- Increasing number of patent filings focusing on biopharmaceuticals and combination therapies.
3.2. Key Patent Families and Similar Patents
A search for patents similar to CL2012001927 indicates that:
- There are numerous patent applications granted or pending covering formulations of active compounds in Chile, often originating from major multinational pharmaceutical companies.
- Latin American patents frequently align with international patents, with many filing strategies applying for patent protection regionally or via WIPO/PCT applications.
3.3. Patent Validity Challenges and Litigation
Pharmaceutical patents in Chile face potential invalidation risks due to:
- Prior art disclosures, including academic publications and earlier patents.
- Obviousness or lack of inventive step, especially in formulation patents with well-known ingredients.
- Patent term adjustments, which are relevant given the public health context and issues around patent evergreening.
3.4. International Patent Landscape
Globally, patents similar to CL2012001927 are often part of larger patent families covering core active compounds, licensing, or formulation improvements. In jurisdictions like the US, EU, and China, similar patents undergo scrutiny regarding novelty and inventive step, influencing Chilean patent enforcement and licensing strategies.
4. Critical Analysis of Patent Strengths and Weaknesses
4.1. Strengths
- Specific formulation or use claims can provide targeted market exclusivity.
- Method claims may protect unique manufacturing processes or administration methods.
- Potentially narrow scope minimizes prior art conflicts and enhances enforceability within Chile.
4.2. Weaknesses
- Broad claims lacking novelty could be vulnerable to invalidation.
- Limited claims may restrict the value of the patent.
- Patent lifecycle considerations: Given the filing date (2012), the patent may be nearing expiration unless it has been extended or supplemented.
4.3. Strategic Implications
- Validation of the patent’s scope is crucial for enforcement strategies.
- Existing patent landscape presents both opportunities for licensing and risks of infringement challenges.
- A comprehensive freedom-to-operate analysis is recommended before commercial deployment.
5. Regulatory and legal considerations
Patent protection in Chile influences regulatory approval and market exclusivity. The invention must align with Chile’s health authority requirements (ANVISA, INFARMED, or equivalent bodies) and be supported by clinical data to maintain enforceability.
Additionally, Chile’s adherence to patent linkage policies impacts generic entry and patent enforcement strategies.
Key Takeaways
- Scope of CL2012001927 likely centers on a specific pharmaceutical formulation or use, with claims crafted to balance broad protection and defensibility.
- Chilean patent landscape reveals a mature environment, with patent validity often challenged on prior art grounds; thus, drafting claims with clear novelty and inventive step is critical.
- International patents on similar drugs inform potential patent challenges, licensing, or cross-licensing opportunities.
- Patent lifecycle and strategic importance depend on current market relevance, patent family status, and regulatory approvals.
- Legal and commercial strategy in Chile benefits from aligning patent claims with specific therapeutic applications and manufacturing methods to maximize enforcement power.
FAQs
Q1: Can CL2012001927 be enforced against generics in Chile?
Yes, if its claims are valid, novel, and non-obvious, enforcement can prevent unauthorized generic marketing within Chile until patent expiry or invalidation.
Q2: How does Chile's patent law affect pharmaceutical patents?
Chile grants patents for pharmaceutical inventions that meet standard criteria; however, legal challenges based on prior art, obviousness, or non-fulfillment of novelty can weaken patent rights.
Q3: Are formulation patents like CL2012001927 common in Chile?
Yes, formulation patents are prevalent in Chile’s pharmaceutical landscape, often focused on specific drug combinations or delivery mechanisms.
Q4: What strategies can extend the patent's effective protection?
Strategies include pediatric extensions, supplementary protection certificates, or patent amendments to cover new formulations or uses.
Q5: How does the patent landscape influence drug innovation in Chile?
A robust patent landscape encourages innovation by providing exclusivity incentives, but overly broad patents can hinder generic entry and competition.
References
- Chilean Patent Office (INAPI). Patent CL2012001927.
- World Intellectual Property Organization (WIPO). Chile patent landscape reports.
- TRIPS Agreement, World Trade Organization.
- Chilean Patent Law (Act No. 19,039).
- International data on pharmaceutical patent trends.
